Nike stock is primed to open near its lowest level in more than a decade after a fiscal first-quarter report that beat on earnings and still managed to rattle anyone hoping the worst was already in the price. Profit came in better than the street expected. Revenue did not. The outlook for the year ahead was the part that landed like a cold floor. Shares dropped about 9 percent before the opening bell and are on track to change hands around $32. Year to date, the decline is roughly 45 percent. That is not a wobble. That is a repricing.
I have found that markets forgive a messy quarter faster than they forgive a vague timeline. This report offered the second kind of problem. Management is cutting costs, clearing old product, and talking about a healthier marketplace sometime later. Later, in this case, may stretch through the next fiscal year and into the one after that. If you came looking for a clean bottom, the desk notes that followed the print were not especially comforting.
Why A Once Dominant Name Is Trading Like A Reset Story
The brand is not broken in the way a forgotten label breaks. You still see the product on feet, in gyms, on sidelines. What looks broken is the mix. Performance footwear is doing the job it is supposed to do. Sportswear, the Jordan franchise, and the China business are not. Those are not side pockets. Together they are large enough that a healthy running line cannot carry the whole company while the rest is being cleaned up.
That is the tension sitting under the quote. A company can post a profit beat and still tell you the next several quarters will be worse. Investors heard both messages on the same afternoon, and they chose the second one. Fair enough. Earnings of 48 cents a share topped a 43-cent consensus. Revenue of $11.21 billion missed a $11.32 billion estimate. Small miss on the top line, larger message underneath it.
Guidance did the heavier lifting. Management expects revenue to fall by a high single-digit percentage in fiscal 2027. Adjusted earnings for the current fiscal year are framed between $1.15 and $1.35. More job cuts are coming as part of a restructuring meant to position the business for longer-term growth. Cost cuts can be sensible. They can also be a tell. When sales visibility is thin, the lever you can still pull is expense.
What The Quarter Actually Proved
A beat is a beat. I will not pretend otherwise. Coming in five cents above the profit number the street had modeled is not nothing, especially after a year in which estimates have already been walked down. The trouble is the quality of that beat. Wholesale and apparel helped offset deeper declines in direct-to-consumer selling and in footwear. If you care about how a consumer brand makes money over a cycle, that mix matters more than the headline cent.
Direct sales are where a company usually captures fuller margin and cleaner data on who is buying. When that channel is soft and wholesale is doing more of the work, you can still print a respectable quarter. You just should not romanticize it. Channel checks cited by skeptical desks point to sell-through risk that has not fully shown up in gross margin yet. Management itself has flagged that risk. So the 48-cent figure may be the best-looking print of the year, not the start of a climb.
Perhaps the most interesting aspect is how ordinary the miss looks on paper. Eleven cents of revenue, in billions, is a rounding error for a company this size. The market did not treat it that way because the miss arrived with a map of the next two years that still has fog on it. A small gap versus consensus becomes a large gap versus hope.
It is simply hard to find good news here. Numbers are coming down again, growth may be two years away, and the valuation does not look cheap against that wait.
Paraphrased desk note after the quarterly report
That line, stripped of the bank letterhead, captures the mood. One equal-weight desk cut its framing of street earnings by roughly a quarter and parked a $30 target on the shares, which implied close to 15 percent downside from the prior close. Others went lower. A couple stayed neutral around the low thirties. One outlier still carries a target in the mid-forties, and even that note reads more like patience than celebration.
The Guide That Reset The Clock
High single-digit revenue decline. Sit with that for a second. This is not a company guiding to flat, with a wink that promotions might save the holiday. It is guiding to a smaller top line while it clears aged lifestyle and Jordan inventory and right-sizes wholesale exposure in China. Margins are expected to land near 6 percent for the year as that cleanup runs. Deleverage is the unglamorous word for what happens when sales fall faster than costs.
Management sounded confident that the new numbers are de-risked. I get why they would say that. After several cuts, you want the latest cut to be the last one. Investors have heard a version of that sentence before. Credibility is not a slide in a deck. It is a sequence of quarters that stop surprising people to the downside. Until that sequence shows up, the phrase “last cut” is a claim, not a fact.
The other timing tell is fiscal 2029. Some of the longer-range initiatives, the ones meant to put pace back into the franchise, are now being described as dial-movers closer to that year. Fiscal 2027 and 2028 are the digestion years. If that framing holds, anyone buying the stock for a quick mean-reversion is early by a wide margin. Early can still be right. It is just expensive in opportunity cost.
Three Businesses Doing The Damage
Performance is the bright room in an otherwise dim house. Running and other sport-specific product are growing in a way that looks healthy. The catch, and it is a large catch, is scale. Performance is only about a third of revenue in the current fiscal setup. You cannot ask one-third of the company to hide the stress in sportswear, Jordan, and China. The math does not cooperate.
Sportswear is the lifestyle engine that carried a lot of the last cycle. When that engine idles, the whole P&L feels it. Jordan sits in a similar place culturally. It is not just a shoe line. It is a pricing umbrella and a wholesale relationship. Clearing aged pairs is the right operational move. It is also a margin and a narrative tax while it happens. Shoppers notice when heat product starts to feel like leftover product.
China remains the sore spot desks keep returning to. Sluggish sales there have weighed on the shares for a while, and the latest commentary does not suggest a quick snapback. Rightsizing the wholesale business in that market is sensible if the prior footprint was ahead of real demand. It also means reported sales can fall even if the brand is not vanishing from the street. Reported sales are what the multiple watches.
- Performance footwear is growing, but it is only about one-third of the revenue base.
- Sportswear and Jordan are still working through aged inventory and softer demand.
- China wholesale is being resized, which keeps pressure on the top line.
- Those three areas are large enough to offset gains elsewhere through fiscal 2028.
Macro does not get a free pass either. Footwear is discretionary even when it is dressed up as sport. A consumer who is picky about big-ticket purchases will also hesitate on a third pair of lifestyle sneakers. Innovation gaps make that hesitation easier. When the new silhouette does not feel new, price promotions do more of the selling, and promotions are a quiet way to give margin back.
Direct Versus Wholesale Is Not A Footnote
I keep coming back to channel mix because it explains why a profit beat can still feel low quality. Wholesale filling a hole left by direct-to-consumer is not the same as demand improving. It can be a timing shift. It can be inventory moving to a partner who will discount it later. Either way, the company has less control over the final price the shopper pays.
Gross margin risk is the shadow on that setup. Management has acknowledged sell-through challenges. If partners need deeper markdowns to move product, the pain shows up with a lag. That is why some underweight notes argue the first quarter does not yet reflect the full margin threat. The quarter you just reported is not always the quarter that contains the bill.
There is a counterpoint, and it is worth stating plainly. Wholesale is not a sin. For a global footwear name, partners are distribution. The question is whether wholesale is a bridge back to health or a mask over weak pull-through. Right now the skeptical read is the mask. A couple of clean sell-through seasons would change that read faster than any slogan.
Cost Cuts Tell You Where Confidence Sits
A $2.5 billion savings program is roughly 5.5 percent of fiscal 2026 sales. That is real money. It is also the language of adaptation. When sportswear, Jordan, and China are expected to stay under pressure through fiscal 2028, you do not wait for volume to save the margin structure. You take cost out and hope volume returns before the culture of the company thins out.
Layoffs are part of that plan. They are never just a line item. Teams that design, sell, and tell the story get smaller while the brand is trying to feel inventive again. Sometimes that focus helps. Sometimes it leaves the pipeline thinner exactly when you need a hit. I do not think outsiders can score that trade from a press release. We can only watch whether the next product cycle looks sharper or smaller.
One neutral desk put it bluntly enough. This is turning into a cost-cutting story. There is little justification, on that view, for a premium multiple versus peers that are actually growing. I agree with the direction of that argument even if the exact multiple is a judgment call. Premiums are paid for visibility. Visibility is what this print did not offer.
| Desk stance | Target area | Core worry |
| Equal weight | $30 | Earnings cuts, growth two years out, valuation not cheap |
| Neutral | $30 | Sportswear, Jordan, and China offset performance gains |
| Underweight | $27 | Low-quality beat, margin risk, weaker quarters ahead |
| Neutral | $32 | Cost story, no case for a premium multiple |
| Underperform | $24 | No clear timing on a sales inflection |
| Outperform | $45 | Cleanup is real, but credibility must be rebuilt |
Targets are opinions with numbers attached. The spread from the mid-twenties to the mid-forties tells you the street is not debating a decimal. It is debating the year the business stops shrinking. That is a wider argument than a single quarterly miss.
How The Street Is Splitting The Difference
Cluster the notes and a pattern shows up. The cautious majority sits between $24 and $32, with ratings that run from underperform to neutral. The shared sentence is some version of this: actions taken to repair the marketplace will hit fiscal 2027 and bleed into fiscal 2028. Margins come under pressure because volume is not there to cover the fixed cost. China does not rescue the print. Jordan does not either.
The underweight case goes a step further on quality. First-quarter profit was helped by wholesale and apparel, not by a revival in direct footwear demand. Management has suggested this may be the best quarter of the year, with sales and earnings growth set to deteriorate from the second quarter through the fourth. If that path is real, buying the open because the stock “already fell 9 percent” is a trade, not a thesis.
The underperform note is simpler, and simplicity has its uses. Visibility on a sales turnaround is limited. Estimates have been cut hard, and downside to the multiple remains until the timing of a revenue inflection is clearer. A $24 target is not a prediction that the brand disappears. It is a statement that a premium can keep compressing while the wait drags.
Then there is the outlier. An outperform rating with a $45 target accepts the slowdown, the inventory clear, and the China wholesale reset, and still sees upside if the new guide holds. Management feels very confident the numbers are de-risked. The same note admits that confidence has to be earned back after a year of cuts. I think that caveat is the honest part. A bull case that depends on this being the last cut is a bull case with a short fuse.
The turnaround strategy and the timeline are still in flux. The November investor day is when the picture should get sharper, not the morning after a single quarter.
November Is The Next Real Checkpoint
Several desks are explicitly waiting for the investor day in November before they redraw the model. That is not cowardice. The company has said it will give more detail on a five-year view then. If fiscal 2029 is the year the pace initiatives are supposed to matter, investors deserve a bridge from here to there that is more than a slogan and a savings target.
What would actually change minds? A clearer split between cleanup and growth. A sense of which franchises get investment and which get harvested. A China plan that is not only “smaller wholesale.” Evidence that performance momentum can spread into adjacent categories instead of living in its own silo. None of that has to arrive as a miracle. It has to arrive as a sequence someone can underwrite.
Until then, the stock is trading the gap. Gap between a still-famous brand and a P&L that is shrinking. Gap between a profit beat and a guide that says the beat was the high point. Gap between cost cuts, which are controllable, and demand, which is not. Markets are pretty good at pricing gaps. They are slower at closing them.
Valuation After A Forty-Five Percent Slide
Down 45 percent in a year invites the reflex that something must be cheap. Sometimes the reflex is right. Here, the pushback from the desks is specific. Earnings power is being revised down, on the order of a 25 percent cut to street profit expectations in at least one note. If the denominator falls with the price, the multiple does not relax as much as the chart suggests.
Put the guided range next to the price and you can do the rough math yourself. At about $32, with adjusted earnings framed between $1.15 and $1.35, you are not looking at a distressed single-digit multiple. You are looking at something that still assumes the earnings trough is temporary. That assumption may be fair. It is not free. If fiscal 2027 revenue falls by a high single-digit rate and margins sit near 6 percent, the trough might be wider than a single year.
Peers that are growing do not need the same leap of faith. That comparison is what the neutral notes keep poking at. A premium is a claim about the future. When the future on offer is two years of repair, the claim has to shrink or the price does. This week the price did.
Rough tape snapshot after the report: Premarket move: about -9 percent Indicated open: near $32 Year-to-date slide: about 45 percent Prior comparable price zone: 2013 Guided revenue: high single-digit decline next fiscal year Guided adjusted EPS: $1.15 to $1.35
None of those figures say the company is finished. They say the market has stopped paying for a turnaround that has not arrived. There is a difference, and it matters if you are underwriting a three-year hold rather than a three-week bounce.
Innovation Is The Quiet Missing Piece
Footwear businesses live and die on the feeling that the next pair is worth the swap. When that feeling fades, you can still sell units. You sell them harder. You lean on heritage colorways, athlete contracts, and wholesale doors. All of that works until the consumer decides the closet is full. Several commentaries this year have pointed at a thin innovation cycle as one reason the franchise has struggled to turn. Macro headwinds did not help. They rarely do.
I do not think innovation is a press-release item. It shows up as full-price sell-through, fewer aged stacks, and a direct channel that stops shrinking. Those are lagging signs, which is annoying if you want a trade today and useful if you want to know whether the fix is real. A cost program cannot design a shoe. It can only buy time for the people who do.
Jordan makes this sharper. The line carries cultural weight that most labels would kill for. Weight becomes a burden when the market is saturated and the new drops feel iterative. Clearing inventory is the adult decision. Rebuilding heat is the harder one, and it does not run on the same calendar as a savings target.
What Could Still Go Right
A fair article has to leave room for the other outcome. Guidance can be beaten. Management all but invited that possibility by sounding confident the bar is now low enough. If sell-through improves faster than the cleanup plan assumes, gross margin risk fades instead of building. China could stabilize rather than keep shrinking. Performance could pull adjacent categories with it.
The $2.5 billion program, if it lands without gutting product, drops straight to the bottom line once sales stop falling. That operating leverage works in reverse on the way down and in the company’s favor on the way up. A stock that has already been cut nearly in half does not need a heroic recovery to produce a respectable return from here. It needs the bleeding to stop on a schedule investors can see.
November is the first place that schedule might get specifics. A five-year outline with real category targets would give the bull case something firmer than a $45 sticker and a hope. I would still want two quarters of evidence after that. Slides are cheap. Full-price pairs are not.
- Watch whether direct-to-consumer stops declining, not just whether wholesale fills the gap.
- Track aged inventory in lifestyle and Jordan. Cleanup has an end date or it does not.
- Treat China as a reported-sales story until wholesale rightsizing is finished.
- Compare the next earnings guide with the $1.15 to $1.35 range. Another cut changes the multiple debate.
- Use the November investor day as a test of timeline, not as a celebration.
Risks That Can Keep The Bid Away
The downside case is not exotic. Revenue keeps sliding at a high single-digit clip for longer than one year. Markdowns to clear Jordan and lifestyle product hit gross margin after the quarter everyone just cheered. China wholesale shrinks and consumer demand there does not replace it. A softer global shopper delays the performance offset. Another estimate cut lands before November, and the “de-risked” claim ages badly.
There is also a multiple risk that is easy to underestimate after a big decline. If investors decide this name should trade with ordinary apparel sellers rather than with premium global brands, the rerating is not finished at $32. The $24 underperform target is basically that argument with a pencil. You do not have to buy the target to respect the mechanism.
Competition sits in the background of every one of these notes even when it is not the headline. Shoppers have more technically credible options in running than they did a decade ago, and more lifestyle options that do not require a legacy logo. Share shifts are slow, then they are not. A year of 45 percent underperformance is what slow-then-sudden looks like on a chart.
A Framework If You Are Tempted By The Price
I am not in the business of telling anyone to buy or sell a single name. I am in the business of noticing when a price and a story have come apart. Here, the price says distress and the story says long repair. Those can coexist. The mistake is treating them as the same signal.
If you need a turnaround inside two quarters, this setup is a poor fit. Management has pointed at fiscal 2027 and 2028 as the years when marketplace repairs still bite, and at something closer to fiscal 2029 before newer initiatives move the dial. That is a long time to be early. Early capital has a cost, even when you are eventually right.
If you can underwrite a multi-year cleanup, the questions get more specific. Is $32 a level where the de-rated multiple already assumes a messy 2027? Does the cost program protect earnings enough if sales fall as guided? Will you add only after direct sales and China stop being the drag, or are you willing to own the drag? Writing those answers down before the next headline is more useful than refreshing the premarket quote. Trust me on the refreshing. It does not clarify much.
Reading The Next Print Without The Noise
The following report will tempt people to trade the cent again. I would watch four lines instead. Direct-to-consumer trend. Footwear versus apparel. China sales and the wholesale mix inside them. Gross margin versus the sell-through warnings already on the table. If those four improve together, the low-quality-beat critique starts to expire. If only the profit cent improves, you are watching the same movie.
Job cuts will generate their own headlines. They matter as a sign of how deep the savings program runs, and as a risk to execution. They do not, by themselves, fix demand. A leaner cost base on a smaller sales base is stability, not growth. Growth is still the missing chapter.
Language is a tell too. Listen for whether “de-risked” survives contact with the next guide. Listen for whether fiscal 2029 gets pulled forward or pushed back. Timeline slippage is how repair stories become value traps. Timeline confirmation is how they become investments. One quarter will not settle it. It will show which way the language is drifting.
The Brand Versus The Stock
It is easy to conflate the two, and the conflation is how people get stubborn. The brand can remain culturally loud while the stock stays cheap for ordinary financial reasons. Shelves can be full. The multiple can still compress if full shelves are full of pairs that needed a markdown to get there. Cultural relevance is an asset. It is not a valuation model.
I have watched other consumer names go through a version of this, where the logo stayed famous and the earnings power did not. The recovery, when it came, followed product and channel, not nostalgia. Nostalgia buys the first bounce. Product buys the second and third year. This franchise has nostalgia in surplus. The open question is product cadence and whether China and lifestyle can stop subtracting.
None of that requires a villain. Retail cycles overshoot. Management teams guide, then reguide, then ask for time. Holders who paid up for a premium two years ago are living with the bill. New buyers are being offered a lower entry and a longer wait. Both groups can be rational. They are just solving different problems.
What The 2013 Echo Actually Means
A thirteen-year low is a headline because it is clean. It is also a bit of a trick. The company is not the company of 2013. Revenue base, geographic mix, direct mix, and the Jordan economy are all different. Trading at a similar price does not mean you are buying the same asset at a discount to history. You are buying today’s earnings power at a price the market last accepted under a different setup.
That distinction keeps people out of lazy comparisons. “It was $32 in 2013 and look what happened next” is not an analysis. What happened next depended on a product cycle and a consumer backdrop that may not rhyme. What matters now is whether fiscal 2027 is the trough year or the first of several. The guide says decline. The cleanup plan says the decline has a purpose. Purpose is not the same as duration.
Still, price has a memory, and so do holders. A level last seen that long ago will attract dip commentary all week. Some of it will be thoughtful. Some of it will be the reflex that anything down 45 percent is owed a bounce. Bounces happen. They are not a business plan, and they are not what the more cautious targets are underwriting.
Putting The Pieces On One Page
So where does that leave a reader who just wanted to know why the stock is on the floor? Profit beat expectations. Revenue missed, slightly. The outlook missed the mood by more than slightly. Sales are guided down at a high single-digit rate. Adjusted earnings for the year sit in a $1.15 to $1.35 band. A multibillion-dollar cost program and further layoffs are the controllable response. Sportswear, Jordan, and China are the uncontrollable drag, expected to last through fiscal 2028. Performance is not big enough to hide that drag. Wholesale made the quarter look cleaner than direct demand did. Margin risk from weak sell-through is still ahead of the numbers, not fully inside them. Most published targets cluster at or below the indicated open. One optimistic target needs the latest cut to be the last cut, and even that note says credibility has to be rebuilt.
That is a lot of weight for one premarket session. It is also a coherent story. The selling is not a mystery, and it is not obviously finished just because the price looks old. Finished would require a revenue inflection someone can date, a margin path that does not depend on hope, and a November outline that survives the next two prints. Until those show up, the shares can stay a debate instead of a destination.
I will keep an eye on the open anyway. Old habits. The more useful work is deciding, before the next headline, whether you are underwriting a cleanup that runs into fiscal 2028 or a bounce that only needs a quiet week. Those are different trades. Only one of them matches what the company just told the market.
Questions Worth Asking Before You Average Down
Are you buying the brand or the earnings path? If the answer is the brand, you should be honest that the brand was famous at $60 too. Fame did not set the multiple. Earnings revisions did. If the answer is the earnings path, write down the year you need growth to return and compare it with the year management is pointing at. A mismatch is not a reason to never own the shares. It is a reason to size them like a wait, not like a catalyst.
How much of your thesis depends on China stabilizing? If the answer is “most of it,” you are making a regional call inside a global ticker. That can work. It should be labeled correctly. How much depends on Jordan feeling hot again? Same exercise. Heat is real, and it is lumpy. A cleanup year is a strange time to underwrite heat.
What would falsify the cautious case? For me it would be two things side by side: direct-to-consumer growth returning while gross margin holds up, and a China print that is no longer the excuse in the shareholder letter. Either one alone can be spun. Together they are harder to spin. Until then, the equal-weight and underweight notes are describing the same company the bull hopes to own later.
Simple hold filter: revenue inflection dated + margin not falling + China no longer the drag = thesis upgrade. Missing one of the three = still a wait.Filters like that feel blunt. Blunt is useful when a famous name is begging you to get sentimental. Sentiment is how thirteen-year lows become stories people tell later. Sometimes the story is “I bought the low.” Sometimes it is “I bought the first low.” The difference is usually whether sales had already turned.
The Part The Quote Will Not Settle
By the time you read this, the open may have bounced, extended the drop, or done nothing dramatic at all. Intraday noise is not the analysis. The analysis is that a global footwear leader just told the market to expect a smaller company next year, thinner margins while inventory clears, and a longer road before newer initiatives show up in the numbers. Analysts who cover the name mostly answered with targets at or below the new price zone. A minority still sees a path higher if this guide holds.
I lean toward the cautious reading, with one reservation. Consumer turnarounds have a habit of looking impossible in the quarter before product clicks, and inevitable two years after. The reservation is not a buy rating. It is a reminder not to confuse a grim guide with a permanent state. Permanent is a strong word for a business that still moves billions of pairs and still has a performance line that is growing. Grim, for the next several quarters, is the word the company chose.
If you want a single takeaway, take this. The profit beat was real. The reason the stock is flirting with a thirteen-year low is also real. Selling does not look finished merely because the chart is ugly. It looks unfinished because the sales turn still does not have a date, the margin risk still sits in front of the printer, and the next serious explanation is scheduled for November rather than delivered today. That is not a slogan. It is the shape of the wait.
]]>
